Extrawell Pharmaceutical Holdings Limited (0858) Income Statement

0 Followers

Extrawell Pharmaceutical Holdings Limited Income Statement

Last quarter (Q4 2024), Extrawell Pharmaceutical Holdings Limited's total revenue was HK$24.64M, a decrease of -35.98% from the same quarter last year. In Q4, Extrawell Pharmaceutical Holdings Limited's net income was HK$121.71M. See Extrawell Pharmaceutical Holdings Limited’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Total Revenue	HK$ 55.43M	HK$ 59.10M	HK$ 72.58M	HK$ 73.92M	HK$ 77.58M
Gross Profit	HK$ 21.87M	HK$ 28.78M	HK$ 31.14M	HK$ 37.56M	HK$ 42.92M
Operating Expenses	HK$ 30.78M	HK$ 35.53M	HK$ 42.30M	HK$ 56.01M	HK$ 59.25M
Depreciation and Amortization	HK$ 8.28M	HK$ 8.91M	HK$ 8.66M	HK$ 8.63M	HK$ 6.30M
EBITDA	HK$ 255.11M	HK$ -129.52M	HK$ 155.20M	HK$ 157.84M	HK$ 101.14M
Operating Income	HK$ -8.91M	HK$ -6.53M	HK$ -11.15M	HK$ -18.46M	HK$ -16.33M
Other Income/Expenses	HK$ 233.63M	HK$ -152.98M	HK$ 145.90M	HK$ 148.43M	HK$ 97.97M
Pretax Income	HK$ 224.72M	HK$ -159.51M	HK$ 134.75M	HK$ 135.98M	HK$ 85.49M
Net Income	HK$ 222.64M	HK$ -162.95M	HK$ 129.26M	HK$ 130.59M	HK$ 83.28M
Per Share Metrics
Basic EPS	HK$ 0.09	HK$ -0.07	HK$ 0.05	HK$ 0.05	HK$ 0.03
Diluted EPS	HK$ 0.07	HK$ -0.07	HK$ 0.04	HK$ 0.04	HK$ 0.03
Weighted Average Shares Outstanding	2.39B	2.39B	2.39B	2.39B	2.39B
Weighted Average Shares Outstanding (Diluted)	3.29B	2.39B	3.29B	3.29B	3.29B

Currency in HKD

Extrawell Pharmaceutical Holdings Limited (0858) Income Statement

Extrawell Pharmaceutical Holdings Limited Income Statement

Extrawell Pharmaceutical Holdings Limited Earnings and Revenue History